- Biotics Press release (OTC: BTCY): Q3 GAAP EPS from – $ 0.05.
- Revenue of $ 3.6 million.
- The company has achieved a positive cash flow on the current operational basis, before paid interest, dividend and depreciation for another consecutive quarter, increased by 114.5% from the previous quarter.
- Gross margins continued to meet the expectations of governance for improvement at 76.4%, a significant improvement of 72.9% for the same period last year.